Hi narmac.

narmac wrote - "Zenith,,well that was flipped off for the sales event,,which of course has not happened and never will imo,"

I'm just trying to understand what you are inferring about Zenith. The Zenith epigenetic portfolio was spun out of RVX back in April of 2013 in order for Don and company to own and control these assets. So if the ASSURE trial on rvx-208 had achieved it's PAV regression target then presumably RVX would have become a target for a buy out. If sold it would provide a huge pool of cash and a revenue stream for Zenith. Then Don and his team could spend then next 15 to 20 years developing the Zenith epigenetic platform to treat solid tumours, hematological cancers and autoimmune diseases AND take it public once significance advances have been achieved.

Are you suggesting that because RVX was not sold then there will be no IPO to raise funds for Zenith?

Also, if I remember correctly, a few months ago there were postings that Zenith was selling shares to a certain class of investors that could invest a minimum of $100,000 for Zenith shares. I wish I new how to easily trace back to these posts. If successful they may have raised significant amounts of money. To me I assumed that these investors would have been looking for a quick return - as per a NASDAQ IPO. I'm probably wrong on this but I don't think someone (other than Dart) would want to wait 10 years for a return on those investments.

Regarding your paragraph 3 I agree completely with you regarding AZ. They seem to be pursuing other directions so if BETonMACE succeeds (and IMHO there is a very high probability that it will) and we know that RVX holds the rvx-208 + rosuvastatin (Crestor) patents the heads will roll at AZ for sure.

All the best. Prayers out to the people of France.

Toinv

<!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:minor-latin;} </style> <![endif]-->